stockrow
Friday 6 November 2026
Export TELA’s income statement to Excel — free account
TELA Bio, Inc.
TELA Healthcare Medical Devices
TELA Bio, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $80.3 million, up 15.8% from fiscal 2024.
- Revenue
- −4.49%
- EPS
- +9.09%
- Free cash flow
- −17.7%
- Total debt
- +35.5%
Quarter to June 2026, against a year earlier
0.84
0.06
+7.69%
Follow TELA
Alert me
TELA Bio, Inc. (TELA) P/E ratio
TELA Bio, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 27 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MDAI Spectral AI, Inc. compare | n/m |
| TELA TELA Bio, Inc. | n/m |
| CVRX CVRx, Inc. compare | n/m |
| RPID Rapid Micro Biosystems, Inc. compare | n/m |
| QTI QT Imaging Holdings, Inc. compare | n/m |
| NSPR InspireMD, Inc. compare | n/m |
| XTNT Xtant Medical Holdings, Inc. compare | n/m |
| ELUT Elutia Inc. compare | 0.6× |
| NSYS Nortech Systems Incorporated compare | 28.4× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)